Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Slow but sure Hook.
Great to see rrao11. Seeing clinical trials around the world for DDD is awesome. It shows the credibility of the science and debunks those who say stem cells don’t work. It ads tons of credibility to what StemSpine will do for CELZ, and that is close. We could be just days or weeks from seeing the clinical trial results for CaverStem, although we already know the results :) It is long long overdue, but the spark is about to be lit here again.
Absolutely are signs of life.... that’s why we are all here, correct?
Like I have said before, I think we will be well on our way this year.
Well said CP. No doubt about it!
Very well said. There are several examples of HIGHER SS stocks running well into the pennies on just some rumors.
The patents and patents pending should have this solid in the pennies.
Our day will come. No worries at all.
Real note conversions we saw the last several weeks should be over for about two months. The selling we see today are the traders who smartly bought in the mid trips selling for a quick profit. Good for them. I am jealous of my smart buddies who added many millions in the trips. But they are not the few selling. Holding for LTCG :)
What’s next? The efficacy report, I bet more offices, more revs and StemSpine.
Only one listed on October 7.... not CELZ.
https://otce.finra.org/otce/dailyList?viewType=Dividends%2FDistributions%2FSplits
Any time. Like it or not, CaverStem and FemCelz are slowly commercializing and we know StemSpine will be doing the same late in 2019 or early 2020. Revs will pick up one of these days and these prices will be long gone. We all know the efficacy paper can drop any time. That alone will disprove much of the FUD. Looking forward to that day.
Anyone who can look objectively look at the patents and patents pending and honestly think the market value around $1 million is correct is not being genuine. This will spike when it all falls into place. Like my counterparts like to point out, it’s happening at a glacial pace, but it’s happening. I can wait :)
The September 2018 note that had to clear by September 20th is done. We should not see so much converting until the next note is due. It would be nice not to see that have to clear! A lot can happen between now and then IMO.
It’s all in the filings. All ya gotta do is read them.
To answer your questions......
They added 100 procedures to the trial, so I would say they have done a hundred and counting. I too wish it was more, but as these folks start spreading the word it will increase. I think Hawaii can be as busy as NM and many more will follow. We shall see soon enough as this picks up steam. As for the rest....
1- I personally don’t care if he is still around or not. Folks come and go in every business. I don’t understand why folks think CELZ will fail without Gary.
2- No idea who that woman is. I never heard any of that.
3- Definitely needs an update, more press for Antonini.
4- I wouldn’t like another update there as well, but they explained that three times in the spring.
5- I would like to see more from him too, but I suspect he has stayed quiet for the same reason the company does.
6- No issues with Ichim. He is plenty active for me.
Like normal we have a difference of opinion. The efficacy is well known and has been for years. Those associated with CELZ, as you call it, know what they speak. What you and I are waiting for is the independent peer review to simply say the same thing. More palatable to the public. Nothing more, nothing less.
We, longs and shorts, chased them to be more quiet because every time they make an announcement of a new office, WE call and harass the office.
IMO, when the report is out and more offices are open, and folks finally understand what CELZ is about, those calls will stop and more normal communications will flow. All how I see it.
Same here CP. nothing has changed for me. The science is there. The only thing different/good/bad is the notes hurt a lot more at this PPS, or, offer a greater opportunity to add at ridiculous prices. Depends on ones POV.
When the efficacy report is out, and other event that I believe will be announced are announced, we will be back in the pennies, easy.
The OS will never be as good as it was, but it’s not a deal breaker. Many stocks are trading in multiple pennies with worse SS.
When the world sees what it wants, off to the races we go.
Just because some of us chased the company to the quiet side, and notes are conversions are higher, doesn’t equal SCAM.
I still think there is tons going on.
CF, you bring up some good points, but I think the wrong conclusion. Everything will change when the paper is out, IMO.
LOL. Whatever brings in revs ;)
The big difference now, at least to me, is the last two pieces of info that the paper is finally submitted and in peer review. Soon is relative. I am good with it being reviewed this year, but I “think” it could be as fast as this month. Like I said months ago, after the last debacle when they announced a new office, we all but forced them into quiet mode. I would bet my next paycheck they have been working hard on training new offices and we will find out about them “soon”. I guessed end of summer. Maybe it will be early Fall.
Bottom line to ME and ME only. The paper will be published and more offices will be announced.
We can debate what soon means. I just keep remember that this is a new start up biotech. Doctors and scientists don’t do anything fast in my world. Red tape and insurance issue can muck things up. We see it as glacial time frame. They see it as forward progress.
I am not as patient at CP cool with 2025, but we will know this year our direction. Little debate there
Agreed Yooperman. The efficacy report will be out very soon IMO, proving what LONGS have been saying all along. We will also see more locations popping up. Great time for me and other longs to add :)
Phd, I am sure that is a rhetorical question, but if not, read the filings.
The filings tell you that "Each note matures.......and is convertible into shares of the company's common stock at a conversion price equal to 60% of the lowest traded price of the company's stock during the 15 trading days preceding the applicable conversion date."
If notes are clearing today, they are obtaining the shares for .0006 and can sell them for .0009 or higher. Not a bad days work I would say.
From the lenders to the strong hopefully.
Sept 2018 note clearing I would guess.
THAT I agree with
Power of their financing. If you read the notes, the company is not getting much for their shares. If the note holders held through the news due, they would do much better. I don’t see much greed here, just the cost of a start up business.
Just the start of a lot more news events Gint. $CELZ
When the efficacy report is released, everything changes. That will be the evidence that stem cells do help people and that CELZ will finds its spot in the marketplace.
It will prove CELZ is NOT a scam as so many feel. A struggling startup that made mistakes, yes, but not a scam by any means.
Re-read the IP they have and let it develop. Most of the offices just opened this year. Give them time to get their footing.
It’s a marathon to wealth, not a sprint. GO CELZ
This is what the INVESTORS KNOW about CELZ.
Don’t trust me or anyone on the blogs.
Do you own DD......
The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem® has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem® ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures. This will become incredibly important as CELZ moves forward.
CaverStem® has been shown to be effective even in patients who do not respond to PDE5 inhibitors, and, unlike PDE5 inhibitors, CaverStem® and FemCelz® is completely safe.
Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk, Sanderson and Hassid). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy.
Two shareholders are among the treated patients and can confirm the ease of the treatment for the patient. Testimonials have been published showing patients have been treated. Follow up testimonials will be published when ready.
CELZ will continually add the new physicians to the CaverStem® website as they come aboard. Interest has been growing across the US and Europe.
To speed up new physician training due to the demand, CELZ added additional medical personnel to travel to each physicians office/area to train.
Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative. DD will tell you that interest in increasing in Europe.
Marketing Director David Brandt has been interviewing patients and is preparing customer testimonial videos. The first ones were posted this week.
CELZ has started treating the first patients with the FemCelz® procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem® affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz® program.
Over 50 domain names have been registered showing that more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
CELZ has begun a series of mailer and email campaigns introducing the CaverStem® procedure to licensed physicians in the areas of urology, OB/GYN, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CELZ reported good replies from the emails.
CELZ has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area. This will become very important as Google ads has cracked down in stem cell treatment advertisements that are not back by a clinical study. CaverStem® will have their clinical study published very soon and will greatly benefit from this.
U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia.
Your DD will show that The current Doctors have been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from all treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction.
A one-year trial has concluded and will PROVE the same results. You can watch for results here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14
CELZ submitted their paper for publication. The Principal Investigator is Dr. Jacob Rajfer, MD University of California, Los Angeles... top notch credentials. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only. This was updated in September 2019 expanded to 140 patents and will be published very soon.
Revenue has now started, CELZ is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. Evidence of this are the scores of patients treated in Rome and NM. From these revenue streams, CELZ anticipates reaching financial self-sufficiency by revenues from sales in 2019.
CELZ signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem® and FemCelz® will generate. This has generated many calls to the vetted doctors.
CELZ anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStem® and FemCelz®), incontinence and infertility. This brand will compliment the CaverStem® and FemCelz® brands.
CaverStem® and FemCelz® are just TWO of SEVERAL patents and patents pending held by CMTH. 4 NEW patents were applied for in 2018.
CELZ anticipates commercialization of StemSpine® in late 2019 or early 2020 bringing online a third revenue source.
Management has already successfully commercialized Medistem providing a large return on investment for the shareholders.
CaverStem®, FemCelz®, StemSpine® & AmnioStemTM have all be TRADEMARKED
We KNOW Caverstem® + FemCelz®+ StemSpine®+ AmnioStemTM will = NASDAQ in time.
No doubt about it Gint. Can it fall back to .001? Of course it can, but the odds of it heading north from this area is significantly higher. Much of the debate on this board since last fall was how will the trial prove or disprove the efficacy of CaverStem®. Some folks even opined that the reason it did not get published many months ago was because it was all a sham, or that the trial proved poor efficacy and was being hidden from public view.
Many others opined that the timing of the paper was largely out of CELZ control and will be out when able.
The fact that the trial paper has now been submitted clears up much of that debate. The efficacy paper is real. It is complete and it has been submitted. AND now an additional 100 patients have been added to the report.
Whether the long delays in filing the paper were related to the process itself, CELZ not having the cash to pay for it, or a wait to add the newest 100 patients is unknown, but what is known is that all “unofficial” reports show that the efficacy paper will do two things.
It will prove that stem cell treatment for ED (CaverStem®) does work and is a simple non surgical, non drug option for patients. And it will prove that since it is a natural treatment, that it has a high success rate.
We have seen evidence that it does not work on everyone, at least based on some chatter in the blogs, but nothing works 100% of the time. None of the surgical procedures do, and none of the risky meds do. But we have also seen that it has worked a high percentage of the time on patients, and even on patients that have severe problems, are younger, and had little to no luck taking the riskier drug options.
Some of the doctors who just started using CaverStem® this year have shown excitement that a “fix” like this could be a HUGE arrow in their quiver and based on how simple the fix is, and how high the efficacy has been “unofficially” it could be a huge huge success.
Some chatter on the blogs is that patients will never risk a non proven injection in too sensitive of an area. I would say that may be the case for some folks, but as an example of human behavior, how many people quickly started vaping when their were no studies of the side effects or damage done to your lungs??? There are few areas in the body more critical than your lungs, yet millions of folks can’t fight the urge and vape daily.
Anyway, the efficacy paper will calm all that chatter as well. We could be just days away from the trial results and it will be a game changer. It will prove CELZ is for real to many on the fence.
Patients, doctors and investors have ALL been waiting on the “proof of concept” before getting in. We will see significant trading when the efficacy paper comes out and can be digested. It will be the start of a major recovery for CELZ IMO.
I still firmly believe we will see new offices opening very soon, a new surge of patients and revenue ramping up heading to self sufficiency. Will that happen in 2019 like hoped, or will it be pushed back to 2020?
My personal opinion is that it will be early in 2020. Too much of what I expected has taken too much time to roll out. It’s all happening, just slower than expected. The efficacy report will push the snowball down the hill faster and I think the offices like NM that are rocking it, will get even busier and be the example that many other offices will follow.
When that happens, likely this fall, revs will pick up fast.
Since at its core, it’s a simple procedure, and a simple training for the physician, there is no reason doctors won’t flock to add CaverStem® to their tool box when the patient demand is there. All that will start in earnest with the efficacy report IMO.
To answer the question.... new highs are very possible. Sub penny PPS is a joke. I also believe that when able, many of the notes and warrants will be paid off and they will never convert and hit the OS. We will see the TV commercials and more and CaverStem®, FemCelz® and soon StemSpine® will all be household names.
And just think. Investors can now buy in under a fifth of a penny. Those investors will easily 10 fold their investment IMO.
This is still true IMO.....
LONGS know that CELZ is a mansion being built on a large piece of property on a beautiful lake. This mansion is big, complex and modern inside with many ground breaking patented trademarked features, and it has taken years to build.
There may have been permitting issues, cost overruns, inspection issues and a host of normal construction problems and delays, but it is slowly being built magnificently nonetheless.
There is great interest in the mansion. Seeing it, many are now interested in the property too, and many are angry and disappointed they didn’t find the location and design the mansion first. The other folks with mansions with blue trim on the same lake are worried because this mansion will be nicer than theirs and will steal all the attention away from them.
Many are so angry and disappointed that their new neighbor will have the nicest, newest, most modern house, they talk bad about it and call it gaudy, ugly, not built right and will never be nice and the builder has broken windows at his office.
Laughing, the owners sit back and patiently wait for it to be completed. They know how nice and groundbreaking it will be. They have no interest in selling it to any other interested parties, because it’s their design, their trademark so to say, and it will be theirs forever.
When it is finally built, and they get their occupancy permit, move in and finish the smallest of details, we will discover it will become one of the finest mansion ever built. Many will admire it, be proud of it, and even feel they had a small part of building it.
Many others will continue to talk bad about it, talk about the owners old address, where he came from, some broken windows during early construction legal battles and empty boxes of trash piled up during construction, but the owner will always smile ;)
Especially when they have plans to expand the mansion with new patented technologies as the years go by.
Correctomundo Carm. The results will be very good and will be out shortly IMO. Just like the longs have been saying for some time. It’s all being done properly by top folks under all the proper protocol.
Nothing has happened as fast as we would all have liked, but there is no doubt CaverStem® is legit, it is being properly tested and is far far away from a scam.
The best thing is that you can add sub penny.... kinda crazy.
Imagine where this will be when the world can read the trial results and the many many doctors who are the fence come calling. :)
Agreed SCR. Longs have said all along that CaverStem and FemCelz were just the start up. StemSpine will be even bigger and AmnioStem will be the monster.
That is the basis why many longs have been buying and saying they are here for years. some through 2025 ;)
It’s a small start up that has some huge patents, and patents pending, that will be a household name in time.
It has clearly taken far longer than many longs, myself included , expected, but nothing has changed.
The technology is there lead by top scientist, and the efficacy report was conducted by a top doctor. more offices will open this summer as predicted.
Whether delayed, or just not having cash to pay for it, the trial is real and much bigger now.
Folks who say it’s fake, or bad, or scam will know more very soon!
It’s bittersweet where the PPS has landed.
It looks bad on the surface, but is a dream come true for longs like me. I have been able to afford far more shares than I purchased in 2018.
Go back and look at all that is here and possible, and realize you can buy in for a fraction of a penny per share.
Just a ridiculous PPS that will explode when folks see the efficacy reports and more.
All IMHO
As I have said numerous, numerous times.... the efficacy report is not a scam, not a failure, not hoax in any way, shape or form. Keep watching!!!! :)
“Identify the correct strategic partner to commercialize the AmnioStem® platform. There has been interest from various parties and all opportunities will be considered.”
Or a merger with the AmnioStem deal ;)
When we are back to .035 many will say it down 50% from .07. Weeeeeeeeeeee
I am taking advantage of the situation we are in whenever possible ;)
Knowwhatimean Vern?
Agreed on all points!!! Great post.
Just take advantage of it. ;)